Skip to main content

Table 2 Baseline clinical characteristics of hospitalized older adults in Togo in 2019 (N = 650)

From: Predictors of three-month mortality among hospitalized older adults in Togo

 

Total

(N = 650)

<  60 years

(N = 274)

≥ 60 years

(N = 376)

p-value

Length of stay (days)

   

0.085*

 Median (IQR)

17 (8–32)

20 (10–34)

16 (8–32)

 

Type of hospitalization services, n(%)

   

0.178**

 Medical

494 (76.0)

201 (73.4)

293 (77.9)

 

 Surgical

156 (24.0)

73 (26.6)

83 (22.1)

 

Health pyramid level of hospital, n(%)

   

0.739**

 Tertiary

566 (87.1)

240 (87.6)

326 (86.7)

 

 Secondary

84 (12.9)

34 (12.4)

50 (13.3)

 

Comorbidities

Diabetes, n(%)

124 (19.1)

37 (13.5)

87 (23.1)

0.002**

Hypertension, n(%)

290 (44.6)

105 (38.3)

185 (49.2)

0.006**

Other cardiovascular diseases, n(%)

87 (13.4)

33 (12.0)

54 (14.4)

0.238**

Osteoarthritis, n(%)

51 (7.8)

16 (5.8)

35 (9.3)

0.104**

Other comorbidities, n(%)

24 (3.7)

6 (2.2)

18 (4.8)

0.511**

Number of comorbidities, n(%)

   

< 0.001**

  0

262 (40.3)

131 (47.8)

131 (34.8)

 

   1

254 (39.1)

104 (38.0)

150 (39.9)

 

   ≥ 2

134 (20.6)

38 (14.2)

95 (25.3)

 

Functional impairment, n(%)

   

0.015**

  None

506 (77.8)

226 (82.5)

280 (74.5)

 

  Moderate/Severe

144 (22.2)

48 (17.5)

96 (25.5)

 

Main diagnoses during hospitalization

Malnutrition, n(%)

   

0.003**

  No

26 (4.0)

18 (6.4)

8 (2.1)

 

  Yes

494 (76.0)

204 (74.5)

290 (77.1)

 

  MD

130 (20.0)

52 (19.0)

78 (20.8)

 

Depression, n(%)

   

0.440**

  No

233 (35.8)

98 (35.8)

135 (35.9)

 

  Yes

317 (48.8)

145 (52.9)

172 (45.7)

 

  MD

100 (15.4)

31 (11.3)

69 (18.4)

 

HIV, n(%)

   

0.001**

  Negative

539 (83.0)

211 (77.0)

328 (87.2)

 

  Positive

38 (5.8)

26 (9.5)

12 (3.2)

 

  MD

73 (11.2)

37 (13.5)

36 (9.6)

 

Other cardiovascular diseasesa, n(%)

111 (17.1)

41 (15.0)

70 (18.6)

0.222**

Other infectionsb, n(%)

91 (14.0)

44 (16.1)

47 (12.5)

0.197**

Stroke, n(%)

81 (12.5)

28 (10.2)

53 (14.1)

0.174**

Malignant diseases, n(%)

75 (11.5)

29 (10.6)

46 (12.2)

0.516**

Fractures and injuries, n(%)

66 (10.2)

40 (14.6)

26 (6.9)

0.001**

Gastrointestinal diseases, n(%)

53 (8.2)

23 (8.4)

30 (8.0)

0.848**

Renal diseases, n(%)

49 (7.5)

16 (5.8)

33 (8.8)

0.161**

Diabetes mellitus, n(%)

31 (4.8)

6 (2.2)

25 (6.6)

0.008**

  1. MD Missing data, *Wilcoxon-Mann-Whitney; **Chi square test
  2. aOther cardiovascular diseases: Cardiomyopathy, congestive heart failure, hypertension
  3. bOther infections: Rhinopharyngitis, Influenza and Pneumopathy